RNIT AI Solutions Ltd
AUTOPALINDRNIT AI Solutions Ltd is strength at full price. The numbers are improving — and a P/E at the 96th percentile of its own range says the market knows.
The sharpest disagreement: profits are rising, but only 15% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch.
The price is in a confirmed uptrend (37 weeks in) while the P/E sits at the 96th percentile of its own 1-year range. Underneath, the last four quarters read improving — profit +54.9% year on year, and 15% of the last 3 years' profit arrived as cash. What settles it: whether the cash starts following the profit.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
RNIT AI Solutions Ltd trades at ₹56.5, in a confirmed uptrend and 37 weeks into that stage. That is +5.6% against its own 200-day average. It sits at 48% of a 52-week range of ₹42 to ₹73. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (9 weeks and counting).
Today the stock is in a confirmed uptrend — week 37 of stage 2, confirmed. At ₹56.5 it trades +5.6% versus its 200-day average and sits at 48% of its 52-week range (₹42–₹73).
Against the market, two honest reads. Cumulative: over the last 8 months the stock moved +8% while the NIFTY 500 moved −3% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (9 weeks and counting; last ahead the week of 2026-06-10) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
RNIT AI Solutions Ltd's story is not scored yet against the markers our research file set on 17 May 2026. Where it sits in its own cycle: POST_RESTRUCTURING_RAMP. Still open: Substantially all FY26 revenue (~100%) is government-sourced. A budget cut, payment delay, or policy shift in one anchor state (Telangana or Andhra Pradesh) is a material revenue event.
Our read, 17 May 2026. A post-NCLT AI SaaS turnaround with government-scale facial recognition — margin expansion real, government dependency the price.
From the numbers. PE cycle analysis is not actionable — only 3 post-restructuring quarters available (classified INSUFFICIENT_DATA by pe_pb_expansion_snapshots). Current PE ~47.7x on TTM EPS of ~₹1.42 (FY26). Comparable small-cap AI SaaS…
From the price. Price stage 2, week 37 — above its 200-day line.
From the research. A post-NCLT AI SaaS turnaround with government-scale facial recognition — margin expansion real, government dependency the price.
🚨 Where they disagree. PE cycle analysis is not actionable — only 3 post-restructuring quarters available (classified INSUFFICIENT_DATA by pe_pb_expansion_snapshots). Current PE ~47.7x on TTM EPS of ~₹1.42 (FY26). Comparable small-cap AI SaaS companies in India trade at 35-55x forward PE. At ₹67.6 price and FY26 EPS ₹1.42, PE is 47.6x — within but at the upper end of comparable range. FY27 EPS extrapolation: if PAT grows 40-60% (₹16.8–19.2 Cr), forward PE at current price is 30-35x — reasonable for a 40-60% growth SaaS business, but the post-NCLT history makes this speculative. Bronze conviction cap applies.
What is proven. A post-NCLT AI SaaS turnaround with government-scale facial recognition — margin expansion real, government dependency the price.
What is not proven yet. Substantially all FY26 revenue (~100%) is government-sourced. A budget cut, payment delay, or policy shift in one anchor state (Telangana or Andhra Pradesh) is a material revenue event.
The test written in advance. Government Contract Concentration — Revenue fully dependent on state procurement — Government Contract Concentration — Revenue fully dependent on state procurement Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute by the next result.
The test written in advance. Regulatory Risk — India DPDP Act 2023 / Biometric Data Privacy — Regulatory Risk — India DPDP Act 2023 / Biometric Data Privacy DPDP Act enforcement rules publication; any state government suspension of FRS-based attendance systems by the next result.
The test written in advance. NCLT / Restructuring Residual Overhang — NCLT / Restructuring Residual Overhang Any BSE regulatory filing on legal challenges to the NCLT order; audit qualifications in FY26 annual report by the next result.
What the company does. FY26 closed with revenue +59.8% YoY to ₹51.5 Cr, EBITDA +108.7% to ₹21.5 Cr (41.7% margin), PAT +66.7% to ₹12 Cr — operating leverage inflecting sharply off a small but growing SaaS base. Nine states, 300+ departments, 15–50 million daily facial identifications — RNIT has quietly become India's largest government-scale FRS SaaS provider, with PM Award for Public Administration 2024 validating the platform. Re-listed Oct 2025, raised ₹26.33 Cr preferential at ₹50/share in Mar 2026, promoter holding jumped from 52% to 67% — insider conviction visible; NCLT restructuring overhang lifting.
| Dial | Now | Was | Why it matters | Watch line |
|---|---|---|---|---|
| Operating Leverage Inflection (SaaS… | HIGH | — | SaaS transaction-based model means each new state government contract adds recurring revenue at near-zero incremental delivery… | Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute |
| Order Book / New State Contract Wins | HIGH | — | 9 states as of FY26 vs implied 5-6 in FY25 — each new state is a step-revenue jump, with Andhra Pradesh Higher Education SLA… | Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute |
| New Product Launch — Nia Gen-AI… | MEDIUM | — | Nia is RNIT's Generative AI companion product — opens enterprise/private sector TAM beyond government FRS. First commercial… | Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute |
| TAM Expansion — Digital India / AI… | MEDIUM | — | GoI's Digital India and state-level AI mandates structurally expand demand for RNIT's e-governance platform across education… | Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute |
Lever 1 · Operating leverage — BUILDING. SaaS transaction-based model means each new state government contract adds recurring revenue at near-zero incremental delivery cost — EBITDA grew 108.7% on 59.8% revenue growth in FY26. What proves it keeps working: Operating Leverage Inflection (SaaS transaction model). It stops working if Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute.
Lever 6 · Order-book wins — BUILDING. 9 states as of FY26 vs implied 5-6 in FY25 — each new state is a step-revenue jump, with Andhra Pradesh Higher Education SLA (3,900 institutions) the most significant FY27 win. What proves it keeps working: Order Book / New State Contract Wins. It stops working if Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute.
Lever 3 · Management change — BUILDING. Nia is RNIT's Generative AI companion product — opens enterprise/private sector TAM beyond government FRS. First commercial deployment visible (APSSDC interview platform). What proves it keeps working: New Product Launch — Nia Gen-AI Conversational Platform. It stops working if Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute.
Lever 14 · A bigger market to sell into — BUILDING. GoI's Digital India and state-level AI mandates structurally expand demand for RNIT's e-governance platform across education, health, social welfare, and municipal verticals. What proves it keeps working: TAM Expansion — Digital India / AI Governance Policy Tailwind. It stops working if Quarterly receivables / revenue ratio; any BSE announcement of contract termination or payment dispute.
Sources: our stock research file (17 May 2026) · quarterly results through Jun 26. The story check is re-scored every results season; the record below never changes.
Revenue Revenue is the top line: everything the company billed its customers in the period.
RNIT AI Solutions Ltd reported ₹7.8 Cr of revenue in the Jun 26 quarter, +25.6% year on year. That is the 5th straight quarter of year-on-year growth. Over 16 years it has compounded at 22.6% a year. The last full year, FY26, came in at ₹52.0 Cr. The last four reported quarters add to ₹53.1 Cr.
Why this happened. RNIT's expansion model is state-by-state, department-by-department. FY26 added Goa (Panchayat FRS-ERP), Lakshadweep (school education FRS), Meghalaya (paid pilot — CM Connect + Meghalaya ONE), and Andhra Pradesh Higher Education (3,900 institutions, 1.3 million users, SaaS model). The BSE order announcements track a contract every 4-6 weeks in Q4 FY26 / Q1 FY27. The Andhra Pradesh Technology Services order (AI-based multilingual interview platform for APSSDC) in January 2026 added an enterprise-skills vertical. Each win both adds revenue and extends the reference list that wins the next state.
FY26 revenue came in at ₹52.0 Cr (+62.5% on the year), capping 16 years at 22.6% compound. The latest quarter (Jun 26) printed ₹7.8 Cr, +25.6% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +58.0% growth against the decade's 22.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +56.7% over the last 4 quarters against +240.1%/yr over the last 8 — rolling over; TTM profit +71.3% vs +420.7%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
RNIT AI Solutions Ltd's operating margin is 35.3% in the Jun 26 quarter, −0.6 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 12 fiscal years the operating margin has ranged −555.0% to 40.0%. The current quarter sits inside that band.
Why this happened. RNIT's government FRS contracts are priced on a per-identification / SaaS subscription basis. Once deployed, the marginal cost of an additional facial identification is minimal — compute and bandwidth, not people. FY26 demonstrated this: revenue +59.8%, EBITDA +108.7%, OPM expanded from 31.9% to 41.7% (+980 bps). Q2 FY26 alone showed PAT +294% QoQ on +119% revenue QoQ — textbook operating leverage step-change as a large Telangana contract ramped to full run-rate. The Andhra Pradesh Higher Education SLA (3,900 institutions, 1.3 million users) signed March 2026 is the next catalyst to ramp through FY27.
The latest quarter's operating margin is 35.3%, −0.6 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged −555.0%–40.0%, and FY26's 40.0% is the top of that band — a record year.
🚨 Why the margin moved: operating margin went −0.6 pp year on year while gross margin went +0.0 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
RNIT AI Solutions Ltd earned ₹1.3 Cr of net profit in the Jun 26 quarter, +54.9% year on year. It is the 5th consecutive quarter of growth. Full-year FY26 profit was ₹12.0 Cr. The 16-year compound rate is 16.8%. That is 16.2% of the quarter's revenue. The same quarter a year earlier earned ₹0.8 Cr.
Jun 26 profit was ₹1.3 Cr, +54.9% year on year — the 5th consecutive quarter of growth. On the full year, FY26 printed ₹12.0 Cr (+71.4%), and the 16-year compound rate is 16.8%.
Why profit moved: revenue contributed +25.6% and the margin −0.6 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +83.8% vs revenue +58.0%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 15% of RNIT AI Solutions Ltd's reported profit arrived as operating cash — a gap worth watching. In FY26 that was ₹11.0 Cr of operating cash against ₹12.0 Cr of profit. After ₹19.0 Cr of capital spending, ₹−8.0 Cr was left as free cash.
FY26: operating cash of ₹11.0 Cr against reported profit of ₹12.0 Cr, leaving free cash of ₹−8.0 Cr after ₹19.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 15% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 15%: the cash cycle held roughly steady between FY14 and FY26 — so conversion tracks profitability rather than the cycle. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: the bigger cash user is investment — capital spending ran 10.0× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
RNIT AI Solutions Ltd's cash conversion cycle runs 146 days in FY26, up from 136 days in FY14. Capital spending ran ₹80.0 Cr over the last 3 years. At FY26 sales of ₹52.0 Cr each day of that cycle holds about ₹0.1 Cr, so roughly ₹21.0 Cr sits inside the business at any moment.
FY26: debtors at 146 days (an asset-light business — no inventory to speak of) — for a full cycle of 146 days, looser than FY14's 136.
In money terms: at FY26 sales of ₹52.0 Cr, each day of the cycle holds about ₹0.1 Cr — so the 146-day loop keeps roughly ₹21.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹80.0 Cr over the last 3 fiscal years against ₹8.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
RNIT AI Solutions Ltd earns a ROCE of 20% in FY26. That is up from a trough of 12% in FY17. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 23.1% net margin on 0.31× asset turns.
FY26 ROCE is 20%, recovered from a FY17 trough of 12% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): 23.1% net margin × 0.31× asset turns × 1.20× balance-sheet leverage ≈ 8.6% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
RNIT AI Solutions Ltd carries ₹18.0 Cr of borrowings against ₹139 Cr of equity in FY26, a debt-to-equity of 0.13. Operating profit covers the interest bill 21×. Over 11 years borrowings went from ₹17.0 Cr to ₹18.0 Cr. Capital spending ran ₹80.0 Cr across the last 3 of those years.
FY26: borrowings of ₹18.0 Cr against equity of ₹139 Cr — a debt-to-equity of 0.13. Operating profit covers the interest bill 21×. Over 11 years borrowings went from ₹17.0 Cr to ₹18.0 Cr while capital spending ran ₹80.0 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 11.0 points of RNIT AI Solutions Ltd over 8 quarters, the biggest move on the register. That takes promoters to 63.2% of the company. Domestic institutions moved −6.0 points over the same window, to 1.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.
Why this happened. Nia is RNIT's flagship Gen-AI product, positioned as a versatile conversational assistant for interview preparation, advisory, and analyst roles. It was the basis for the APTS award in January 2026 (AI-based multilingual interview platform for Andhra Pradesh Skill Development Corporation). Nia represents the second growth engine: government FRS is the core, but Gen-AI opens enterprise and edtech verticals where pricing power and TAM are structurally larger. At this stage, Nia is early — revenue contribution not separately disclosed. Risk: competition from well-capitalized national and global Gen-AI players.
The register over the last two years — Promoters: +11.0 points over 8 quarters to 63.2%; Domestic institutions: −6.0 points over 8 quarters to 1.7%; Foreign institutions: −0.2 points over 8 quarters to 0.0%.
Why the register moved: promoters drove it (+11.0 points), absorbed on the other side by domestic institutions (−6.0 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
RNIT AI Solutions Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
RNIT AI Solutions Ltd trades at 51.8× P/E, at the pricey end of its own range (96th percentile). Its long-run median P/E is 42.9×, measured across 0.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 51.8× is at the pricey end of its own range (96th percentile), against a long-run median of 42.9× measured over 0.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
RNIT AI Solutions Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 7 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +62.5% | — | — | +2.7% |
| Profit | +71.4% | — | — | — |
| EPS | +47.9% | — | — | −0.1% |
4-Factor Sector Score
50.5/100 — rank 35 of 64 in IT - Software · 55% evidence confidence
RNIT AI Solutions Ltd scores 50.5 out of 100 against the 64 companies it is compared with in IT - Software, ranking 35. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 16.9 + 14.6 + 9 + 10 = 50.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Coforge LtdCOFORGE | 75.8/100Favorable setup100% evidence | BREAKING OUT | 30.0/35 Revenue 35.7% · PAT 66.5% · OPM change 3 pp 100% evidence | 15.7/25 ROCE 23.5% · OPM 19% 100% evidence | 12.6/20 P/E 41.9× · PEG 0.57 100% evidence | 17.5/20 RS sector 8.3% · RS bench 12.6% · 1Y 10.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30 + 15.7 + 12.6 + 17.5 = 75.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Silver Touch Technologies LtdSILVERTUC | 72.6/100Favorable setup93% evidence | LEADER | 30.3/35 Revenue 21.1% · PAT 86.4% · OPM change 8 pp 100% evidence | 17.5/25 ROCE 29.8% · OPM 22% 100% evidence | 10.2/20 P/E 63.7× · PEG 1.11 65% evidence | 14.6/20 RS sector 44% · RS bench 52.8% · 1Y 165.2%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.3 + 17.5 + 10.2 + 14.6 = 72.6 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 3ASM Technologies Ltd526433 | 67.5/100Favorable setup69% evidence | TURNING | 27.9/35 Revenue 67.8% · PAT 89.5% · OPM change 2 pp 95% evidence | 16.1/25 ROCE 27% · OPM 23% 76% evidence | 8.7/20 P/E 96.6× · PEG — 15% evidence | 14.8/20 RS sector 5.7% · RS bench 39.5% · 1Y 70.7%10 of 10 weeks ahead 70% evidence |
| Exact sum: 27.9 + 16.1 + 8.7 + 14.8 = 67.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4InfoBeans Technologies LtdINFOBEAN | 66.7/100Favorable setup81% evidence | ASLEEP | 26.6/35 Revenue 35.5% · PAT 60.4% · OPM change 0 pp 95% evidence | 16.9/25 ROCE 29.2% · OPM 21% 95% evidence | 9.4/20 P/E 18.5× · PEG — 50% evidence | 13.8/20 RS sector 17.4% · RS bench -1.4% · 1Y 18.7%4 of 10 weeks ahead 70% evidence |
| Exact sum: 26.6 + 16.9 + 9.4 + 13.8 = 66.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 5NINtec Systems LtdNINSYS | 65.4/100Favorable setup80% evidence | LEADER | 20.2/35 Revenue 21.6% · PAT 18.8% · OPM change 4.2 pp 95% evidence | 21.9/25 ROCE 55% · OPM 25.9% 95% evidence | 9.2/20 P/E 40.9× · PEG — 15% evidence | 14.1/20 RS sector 37.4% · RS bench 43.6% · 1Y 73.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 20.2 + 21.9 + 9.2 + 14.1 = 65.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Tech Mahindra LtdTECHM | 63.6/100Mixed-positive evidence94% evidence | TURNING | 21.4/35 Revenue 10.9% · PAT 14.3% · OPM change 3 pp 100% evidence | 16.3/25 ROCE 23.1% · OPM 17% 100% evidence | 10.8/20 P/E 30.1× · PEG 0.76 100% evidence | 15.1/20 RS sector 14.8% · RS bench 6.9% · 1Y 10.4%5 of 11 weeks ahead 70% evidence |
| Exact sum: 21.4 + 16.3 + 10.8 + 15.1 = 63.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Cigniti Technologies LtdCIGNITITEC | 63.3/100Mixed-positive evidence79% evidence | 23.4/35 Revenue 14% · PAT 96.1% · OPM change 2 pp 56% evidence | 16.2/25 ROCE 34.1% · OPM 18% 75% evidence | 16.0/20 P/E 11.4× · PEG 0.61 100% evidence | 7.7/20 RS sector -9.5% · RS bench -15% · 1Y -16.2%0 of 12 weeks ahead to 2026-05-17 100% evidence | |
| Exact sum: 23.4 + 16.2 + 16 + 7.7 = 63.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Sahana Systems LtdSAHANA | 63.2/100Mixed-positive evidence70% evidence | BASING | 21.6/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 19.8/25 ROCE 39.8% · OPM 29% 95% evidence | 14.5/20 P/E 12.3× · PEG — 50% evidence | 7.3/20 RS sector -19% · RS bench -1.3% · 1Y -31.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 19.8 + 14.5 + 7.3 = 63.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Datamatics Global Services LtdDATAMATICS | 62.9/100Mixed-positive evidence94% evidence | TURNING | 21.1/35 Revenue 13.1% · PAT 1.9% · OPM change 4 pp 100% evidence | 16.1/25 ROCE 20.8% · OPM 20% 100% evidence | 11.3/20 P/E 20.2× · PEG 0.58 100% evidence | 14.4/20 RS sector 9.6% · RS bench 3.9% · 1Y -12.5%6 of 10 weeks ahead 70% evidence |
| Exact sum: 21.1 + 16.1 + 11.3 + 14.4 = 62.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Hypersoft Technologies Ltd539724 | 62.8/100Mixed-positive evidence61% evidence | LEADER | 25.5/35 Revenue 100% · PAT 100% · OPM change 2.9 pp 71% evidence | 11.8/25 ROCE 20.6% · OPM 14% 76% evidence | 8.6/20 P/E 433× · PEG — 15% evidence | 16.9/20 RS sector 65% · RS bench 74.2% · 1Y 199.2%12 of 12 weeks ahead 70% evidence |
| Exact sum: 25.5 + 11.8 + 8.6 + 16.9 = 62.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11TAC Infosec LtdTAC | 62.1/100Mixed-positive evidence66% evidence | TURNING | 25.6/35 Revenue 76.4% · PAT 59.4% · OPM change 1.6 pp 71% evidence | 20.8/25 ROCE 38.1% · OPM 48.2% 95% evidence | 9.4/20 P/E 35.3× · PEG — 15% evidence | 6.3/20 RS sector -13.2% · RS bench -12% · 1Y 15.7%1 of 10 weeks ahead 70% evidence |
| Exact sum: 25.6 + 20.8 + 9.4 + 6.3 = 62.1 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.2% and the one-year return is 15.7%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 12Sasken Technologies LtdSASKEN | 61.8/100Mixed-positive evidence100% evidence | LEADER | 30.8/35 Revenue 67.8% · PAT 67.4% · OPM change 4 pp 100% evidence | 8.1/25 ROCE 9.9% · OPM 9% 100% evidence | 9.5/20 P/E 40.6× · PEG 0.68 100% evidence | 13.4/20 RS sector 18.7% · RS bench 24.2% · 1Y 33.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.8 + 8.1 + 9.5 + 13.4 = 61.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13IZMO LtdIZMO | 61.0/100Mixed-positive evidence81% evidence | TURNING | 24.3/35 Revenue 24.7% · PAT 10.2% · OPM change 8 pp 95% evidence | 14.2/25 ROCE 12.6% · OPM 25% 95% evidence | 6.7/20 P/E 26.2× · PEG — 50% evidence | 15.8/20 RS sector 28.9% · RS bench 15.7% · 1Y 160.2%8 of 10 weeks ahead 70% evidence |
| Exact sum: 24.3 + 14.2 + 6.7 + 15.8 = 61 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14String Metaverse Ltd534535 | 59.5/100Mixed-positive evidence82% evidence | BASING | 27.3/35 Revenue 100% · PAT 100% · OPM change 0 pp 95% evidence | 15.6/25 ROCE 41.6% · OPM 11% 76% evidence | 14.7/20 P/E 7.9× · PEG — 50% evidence | 1.9/20 RS sector -60.9% · RS bench -52.1% · 1Y -74%0 of 12 weeks ahead 100% evidence |
| Exact sum: 27.3 + 15.6 + 14.7 + 1.9 = 59.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -60.9% and the one-year return is -74%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 15Softtech Engineers LtdSOFTTECH | 58.7/100Mixed-positive evidence80% evidence | FADING | 25.5/35 Revenue 35.8% · PAT 100% · OPM change -0.1 pp 95% evidence | 12.1/25 ROCE 6.2% · OPM 27.2% 95% evidence | 8.7/20 P/E 118× · PEG — 15% evidence | 12.4/20 RS sector 10.5% · RS bench 15.3% · 1Y 11.2%10 of 12 weeks ahead 100% evidence |
| Exact sum: 25.5 + 12.1 + 8.7 + 12.4 = 58.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16BLS E-Services LtdBLSE | 58.3/100Mixed-positive evidence75% evidence | LEADER | 19.0/35 Revenue 71.2% · PAT 9.4% · OPM change 0 pp 95% evidence | 10.6/25 ROCE 17% · OPM 7% 76% evidence | 9.0/20 P/E 49.1× · PEG — 15% evidence | 19.7/20 RS sector 47% · RS bench 53.4% · 1Y 70.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 10.6 + 9 + 19.7 = 58.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Ksolves India LtdKSOLVES | 57.3/100Mixed-positive evidence87% evidence | ASLEEP | 18.0/35 Revenue 16% · PAT 16.7% · OPM change 3.9 pp 95% evidence | 20.7/25 ROCE 131% · OPM 30.3% 95% evidence | 13.6/20 P/E 17.7× · PEG — 50% evidence | 5.0/20 RS sector -12.5% · RS bench -8.4% · 1Y -11.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 20.7 + 13.6 + 5 = 57.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Infosys LtdINFY | 57.0/100Mixed-positive evidence82% evidence | BASING | 18.3/35 Revenue 11.2% · PAT 11.1% · OPM change 0 pp 95% evidence | 20.0/25 ROCE 40% · OPM 24% 76% evidence | 13.9/20 P/E 15.2× · PEG — 50% evidence | 4.8/20 RS sector -19.8% · RS bench -16.1% · 1Y -17.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.3 + 20 + 13.9 + 4.8 = 57 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Expleo Solutions LtdEXPLEOSOL | 56.8/100Mixed-positive evidence81% evidence | ASLEEP | 20.8/35 Revenue 10.4% · PAT 39.4% · OPM change 4 pp 95% evidence | 15.8/25 ROCE 24.2% · OPM 15% 95% evidence | 13.8/20 P/E 8.6× · PEG — 50% evidence | 6.4/20 RS sector -13.4% · RS bench -9.8% · 1Y -24.9%4 of 10 weeks ahead 70% evidence |
| Exact sum: 20.8 + 15.8 + 13.8 + 6.4 = 56.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Subex LtdSUBEXLTD | 56.5/100Mixed-positive evidence65% evidence | TURNING | 24.4/35 Revenue 2.8% · PAT 100% · OPM change 13 pp 95% evidence | 10.3/25 ROCE 12.8% · OPM 19% 95% evidence | 9.9/20 P/E 24.2× · PEG — 15% evidence | 11.9/20 RS sector — · RS bench 19.3% · 1Y —4 of 4 weeks ahead 25% evidence |
| Exact sum: 24.4 + 10.3 + 9.9 + 11.9 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21R Systems International LtdRSYSTEMS | 55.6/100Mixed-positive evidence100% evidence | ASLEEP | 18.9/35 Revenue 24.1% · PAT -1% · OPM change 3 pp 100% evidence | 16.4/25 ROCE 19.5% · OPM 18% 100% evidence | 18.2/20 P/E 13.6× · PEG 0.26 100% evidence | 2.1/20 RS sector -31.2% · RS bench -28.6% · 1Y -40.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 16.4 + 18.2 + 2.1 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22LTM LtdLTM | 55.3/100Mixed-positive evidence100% evidence | TURNING | 17.4/35 Revenue 13.9% · PAT 10% · OPM change 1 pp 100% evidence | 17.9/25 ROCE 29.6% · OPM 18% 100% evidence | 11.2/20 P/E 24.9× · PEG 1.18 100% evidence | 8.8/20 RS sector -12.4% · RS bench -8.5% · 1Y -7.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 17.9 + 11.2 + 8.8 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23AvenuesAI LtdCCAVENUE | 55.3/100Mixed-positive evidence87% evidence | BREAKING OUT | 21.1/35 Revenue 100% · PAT 43.8% · OPM change -2.3 pp 100% evidence | 8.3/25 ROCE 7.7% · OPM 3.7% 100% evidence | 15.1/20 P/E 18.1× · PEG 0.37 65% evidence | 10.8/20 RS sector -2.2% · RS bench 3.2% · 1Y 12.9%6 of 11 weeks ahead 70% evidence |
| Exact sum: 21.1 + 8.3 + 15.1 + 10.8 = 55.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24TechNVision Ventures LtdTECHNVISN | 54.2/100Mixed-positive evidence74% evidence | ASLEEP | 26.1/35 Revenue 23.4% · PAT 100% · OPM change 2.9 pp 95% evidence | 5.6/25 ROCE 12.9% · OPM 5.2% 95% evidence | 8.5/20 P/E 1093× · PEG — 15% evidence | 14.0/20 RS sector 32.1% · RS bench -2% · 1Y 38.7%0 of 7 weeks ahead 70% evidence |
| Exact sum: 26.1 + 5.6 + 8.5 + 14 = 54.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Tanla Platforms LtdTANLA | 53.6/100Mixed-positive evidence94% evidence | TURNING | 14.5/35 Revenue 13.2% · PAT 9.9% · OPM change 0 pp 100% evidence | 16.5/25 ROCE 26.3% · OPM 16% 100% evidence | 13.1/20 P/E 14.5× · PEG 1.21 100% evidence | 9.5/20 RS sector -12% · RS bench 8.9% · 1Y -0.8%9 of 10 weeks ahead 70% evidence |
| Exact sum: 14.5 + 16.5 + 13.1 + 9.5 = 53.6 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 26HCL Technologies LtdHCLTECH | 53.3/100Mixed-positive evidence76% evidence | TURNING | 12.4/35 Revenue 12.6% · PAT 2.6% · OPM change 0 pp 95% evidence | 19.0/25 ROCE 30.4% · OPM 20% 76% evidence | 9.5/20 P/E 20.4× · PEG — 50% evidence | 12.4/20 RS sector 9.9% · RS bench -6.5% · 1Y -8.1%2 of 10 weeks ahead 70% evidence |
| Exact sum: 12.4 + 19 + 9.5 + 12.4 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Danlaw Technologies India Ltd532329 | 53.3/100Mixed-positive evidence60% evidence | 15.9/35 Revenue 10.9% · PAT 14% · OPM change 0.8 pp 95% evidence | 15.6/25 ROCE 27.2% · OPM 13.4% 76% evidence | 9.6/20 P/E 26.6× · PEG — 15% evidence | 12.2/20 RS sector — · RS bench 44% · 1Y — 25% evidence | |
| Exact sum: 15.9 + 15.6 + 9.6 + 12.2 = 53.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Saksoft LtdSAKSOFT | 52.8/100Mixed-positive evidence94% evidence | BREAKING OUT | 18.1/35 Revenue 8.2% · PAT 13% · OPM change 0 pp 100% evidence | 15.6/25 ROCE 25.5% · OPM 18% 100% evidence | 13.1/20 P/E 16.4× · PEG 0.6 100% evidence | 6.0/20 RS sector -21.2% · RS bench -6.1% · 1Y -23.9%7 of 11 weeks ahead 70% evidence |
| Exact sum: 18.1 + 15.6 + 13.1 + 6 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Xchanging Solutions LtdXCHANGING | 52.8/100Mixed-positive evidence81% evidence | ASLEEP | 18.7/35 Revenue 8.4% · PAT 13.2% · OPM change 1 pp 95% evidence | 15.4/25 ROCE 18% · OPM 34% 95% evidence | 13.4/20 P/E 11.7× · PEG — 50% evidence | 5.3/20 RS sector -24.4% · RS bench -10.8% · 1Y -22.1%1 of 10 weeks ahead 70% evidence |
| Exact sum: 18.7 + 15.4 + 13.4 + 5.3 = 52.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30Seshaasai Technologies LtdSTYL | 52.4/100Mixed-positive evidence73% evidence | TURNING | 12.8/35 Revenue 6.7% · PAT 20.6% · OPM change 0 pp 100% evidence | 17.1/25 ROCE 27.7% · OPM 23% 100% evidence | 12.5/20 P/E 25× · PEG 0.81 65% evidence | 10.0/20 RS sector — · RS bench — · 1Y —9 of 10 weeks ahead 0% evidence |
| Exact sum: 12.8 + 17.1 + 12.5 + 10 = 52.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Tata Consultancy Services LtdTCS | 52.1/100Mixed-positive evidence94% evidence | ASLEEP | 10.3/35 Revenue 7.7% · PAT 1.1% · OPM change -1 pp 100% evidence | 22.5/25 ROCE 63% · OPM 26% 100% evidence | 11.8/20 P/E 15.9× · PEG 1.85 100% evidence | 7.5/20 RS sector -4.6% · RS bench -12.5% · 1Y -19.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 10.3 + 22.5 + 11.8 + 7.5 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 32Dynacons Systems & Solutions LtdDSSL | 51.8/100Mixed-positive evidence87% evidence | FADING | 16.9/35 Revenue 10.5% · PAT 16.2% · OPM change 3 pp 95% evidence | 15.5/25 ROCE 29.8% · OPM 13% 95% evidence | 7.9/20 P/E 18× · PEG — 50% evidence | 11.5/20 RS sector 6.8% · RS bench 12.2% · 1Y 23.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 15.5 + 7.9 + 11.5 = 51.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33Birlasoft LtdBSOFT | 51.5/100Mixed-positive evidence100% evidence | BASING | 19.9/35 Revenue 1.4% · PAT 21.1% · OPM change 4 pp 100% evidence | 13.1/25 ROCE 21.2% · OPM 16% 100% evidence | 14.4/20 P/E 14.6× · PEG 0.62 100% evidence | 4.1/20 RS sector -19.2% · RS bench -15.2% · 1Y -14.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.9 + 13.1 + 14.4 + 4.1 = 51.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 34Capillary Technologies India LtdCAPILLARY | 50.6/100Mixed-positive evidence63% evidence | ASLEEP | 27.6/35 Revenue 27.8% · PAT 135.8% · OPM change 5.8 pp 100% evidence | 4.2/25 ROCE 3.4% · OPM 15.7% 100% evidence | 8.8/20 P/E 83.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —0 of 10 weeks ahead 0% evidence |
| Exact sum: 27.6 + 4.2 + 8.8 + 10 = 50.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 35RNIT AI Solutions Ltdthis pageAUTOPALIND | 50.5/100Thin evidence · provisional55% evidence | 16.9/35 Revenue 59.8% · PAT 66.7% · OPM change -0.6 pp 95% evidence | 14.6/25 ROCE 20.2% · OPM 35.3% 76% evidence | 9.0/20 P/E 51.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 9 weeks ahead 0% evidence | |
| Exact sum: 16.9 + 14.6 + 9 + 10 = 50.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Blue Cloud Softech Solutions Ltd539607 | 49.9/100Mixed-negative evidence69% evidence | ASLEEP | 20.5/35 Revenue 25.7% · PAT 39.5% · OPM change 10 pp 95% evidence | 11.4/25 ROCE 14.2% · OPM 20% 76% evidence | 9.5/20 P/E 32.5× · PEG — 15% evidence | 8.5/20 RS sector -1.9% · RS bench -14.2% · 1Y -25%0 of 10 weeks ahead 70% evidence |
| Exact sum: 20.5 + 11.4 + 9.5 + 8.5 = 49.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 37Wipro LtdWIPRO | 49.7/100Mixed-negative evidence94% evidence | ASLEEP | 13.1/35 Revenue 6.4% · PAT -1.7% · OPM change 0 pp 100% evidence | 15.1/25 ROCE 17.8% · OPM 19% 100% evidence | 13.1/20 P/E 13.8× · PEG 1.4 100% evidence | 8.4/20 RS sector -1.9% · RS bench -17.2% · 1Y -21.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 13.1 + 15.1 + 13.1 + 8.4 = 49.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 38Mastek LtdMASTEK | 49.7/100Mixed-negative evidence82% evidence | TURNING | 13.9/35 Revenue 6% · PAT 5% · OPM change 0 pp 95% evidence | 13.6/25 ROCE 18% · OPM 15% 76% evidence | 12.7/20 P/E 13× · PEG — 50% evidence | 9.5/20 RS sector -10.5% · RS bench -6.9% · 1Y -26.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 13.9 + 13.6 + 12.7 + 9.5 = 49.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 39Mphasis LtdMPHASIS | 48.4/100Mixed-negative evidence94% evidence | TURNING | 15.3/35 Revenue 13.7% · PAT 9.9% · OPM change -1 pp 100% evidence | 17.3/25 ROCE 22.1% · OPM 18% 100% evidence | 5.5/20 P/E 25.1× · PEG 2.19 100% evidence | 10.3/20 RS sector 0% · RS bench -4.8% · 1Y -8.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 15.3 + 17.3 + 5.5 + 10.3 = 48.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 40Hexaware Technologies LtdHEXT | 48.1/100Mixed-negative evidence94% evidence | TURNING | 14.3/35 Revenue 13% · PAT 1.2% · OPM change 4 pp 100% evidence | 17.8/25 ROCE 30.1% · OPM 16% 100% evidence | 10.5/20 P/E 24.6× · PEG 0.81 100% evidence | 5.5/20 RS sector -21.4% · RS bench -9.9% · 1Y -21.5%7 of 10 weeks ahead 70% evidence |
| Exact sum: 14.3 + 17.8 + 10.5 + 5.5 = 48.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 41Zensar Technologies LtdZENSARTECH | 47.6/100Mixed-negative evidence100% evidence | BASING | 16.0/35 Revenue 8% · PAT 15.3% · OPM change 0 pp 100% evidence | 13.7/25 ROCE 22.8% · OPM 15% 100% evidence | 13.3/20 P/E 14× · PEG 1.11 100% evidence | 4.6/20 RS sector -26.3% · RS bench -23.3% · 1Y -36.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16 + 13.7 + 13.3 + 4.6 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 42Sonata Software LtdSONATSOFTW | 47.6/100Mixed-negative evidence97% evidence | FADING | 9.5/35 Revenue 4% · PAT 7.9% · OPM change 0 pp 95% evidence | 13.7/25 ROCE 30.7% · OPM 5% 95% evidence | 12.8/20 P/E 18.1× · PEG 0.81 100% evidence | 11.6/20 RS sector -4.7% · RS bench -0.9% · 1Y -7.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 9.5 + 13.7 + 12.8 + 11.6 = 47.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 43XT Global Infotech LtdXTGLOBAL | 46.6/100Mixed-negative evidence61% evidence | 18.7/35 Revenue 85.4% · PAT 29.4% · OPM change -6.6 pp 53% evidence | 9.4/25 ROCE 7.5% · OPM 9.5% 71% evidence | 9.5/20 P/E 40.8× · PEG — 50% evidence | 9.0/20 RS sector -1.1% · RS bench -12.7% · 1Y -10.3%2 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 18.7 + 9.4 + 9.5 + 9 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 44Unicommerce eSolutions LtdUNIECOM | 45.7/100Mixed-negative evidence74% evidence | ASLEEP | 14.7/35 Revenue 38.4% · PAT 18.1% · OPM change -8.1 pp 95% evidence | 16.6/25 ROCE 21.1% · OPM 10.6% 95% evidence | 9.1/20 P/E 45.5× · PEG — 15% evidence | 5.3/20 RS sector -14.5% · RS bench -24.9% · 1Y -28.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 14.7 + 16.6 + 9.1 + 5.3 = 45.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 45Excelsoft Technologies LtdEXCELSOFT | 44.7/100Mixed-negative evidence60% evidence | ASLEEP | 12.1/35 Revenue 26.8% · PAT 4.2% · OPM change -1.8 pp 95% evidence | 12.1/25 ROCE 13.6% · OPM 16.3% 95% evidence | 10.5/20 P/E 17× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 10 weeks ahead 0% evidence |
| Exact sum: 12.1 + 12.1 + 10.5 + 10 = 44.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4663 Moons Technologies Ltd63MOONS | 42.3/100Thin evidence · provisional58% evidence | BREAKING OUT | 20.6/35 Revenue 100% · PAT -80% · OPM change 128 pp 71% evidence | 3.4/25 ROCE -3.7% · OPM -52% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.3/20 RS sector -22.4% · RS bench 15.5% · 1Y -6.1%8 of 11 weeks ahead 70% evidence |
| Exact sum: 20.6 + 3.4 + 10 + 8.3 = 42.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 47Magellanic Cloud LtdMCLOUD | 39.1/100Mixed-negative evidence81% evidence | FADING | 9.8/35 Revenue 13.7% · PAT 6.7% · OPM change -7 pp 95% evidence | 13.9/25 ROCE 19.8% · OPM 28% 95% evidence | 11.9/20 P/E 15× · PEG — 50% evidence | 3.5/20 RS sector -54.5% · RS bench -25.6% · 1Y -66%5 of 11 weeks ahead 70% evidence |
| Exact sum: 9.8 + 13.9 + 11.9 + 3.5 = 39.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 48Innovana Thinklabs LtdINNOVANA | 38.5/100Mixed-negative evidence81% evidence | ASLEEP | 8.9/35 Revenue 26% · PAT -39% · OPM change -32.5 pp 95% evidence | 11.6/25 ROCE 16.4% · OPM 17.6% 95% evidence | 9.2/20 P/E 21.4× · PEG — 50% evidence | 8.8/20 RS sector -0.4% · RS bench -21.6% · 1Y -36.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.9 + 11.6 + 9.2 + 8.8 = 38.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 49Mindteck (India) LtdMINDTECK | 37.2/100Mixed-negative evidence81% evidence | ASLEEP | 8.1/35 Revenue -1.8% · PAT 0.3% · OPM change -1.7 pp 95% evidence | 10.4/25 ROCE 15.1% · OPM 7.8% 95% evidence | 11.8/20 P/E 17.2× · PEG — 50% evidence | 6.9/20 RS sector -10.1% · RS bench -11.7% · 1Y -0.1%3 of 10 weeks ahead 70% evidence |
| Exact sum: 8.1 + 10.4 + 11.8 + 6.9 = 37.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 50Aurionpro Solutions LtdAURIONPRO | 36.7/100Mixed-negative evidence93% evidence | ASLEEP | 13.2/35 Revenue 14.8% · PAT 5.1% · OPM change -3 pp 100% evidence | 10.6/25 ROCE 16.3% · OPM 17% 100% evidence | 9.9/20 P/E 19.4× · PEG 1.39 65% evidence | 3.0/20 RS sector -31% · RS bench -28.2% · 1Y -48.1%2 of 12 weeks ahead 100% evidence |
| Exact sum: 13.2 + 10.6 + 9.9 + 3 = 36.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 51Kellton Tech Solutions LtdKELLTONTEC | 36.5/100Mixed-negative evidence81% evidence | ASLEEP | 10.2/35 Revenue 9.5% · PAT 9.6% · OPM change -1 pp 95% evidence | 9.7/25 ROCE 15% · OPM 11% 95% evidence | 11.5/20 P/E 8× · PEG — 50% evidence | 5.1/20 RS sector -18.8% · RS bench -25.4% · 1Y -45.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 10.2 + 9.7 + 11.5 + 5.1 = 36.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 52Allied Digital Services LtdADSL | 35.9/100Mixed-negative evidence74% evidence | ASLEEP | 14.5/35 Revenue 19.1% · PAT 5.6% · OPM change 0 pp 95% evidence | 6.5/25 ROCE 7.4% · OPM 9% 95% evidence | 10.6/20 P/E 16.4× · PEG — 15% evidence | 4.3/20 RS sector -29.8% · RS bench -20% · 1Y -30.9%4 of 10 weeks ahead 70% evidence |
| Exact sum: 14.5 + 6.5 + 10.6 + 4.3 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 53Moschip Technologies LtdMOSCHIP | 29.7/100Adverse evidence87% evidence | ASLEEP | 7.8/35 Revenue 8.4% · PAT -33.6% · OPM change -3.9 pp 100% evidence | 7.1/25 ROCE 11% · OPM 8.2% 100% evidence | 3.6/20 P/E 127× · PEG 5.04 65% evidence | 11.2/20 RS sector 1.9% · RS bench -4.1% · 1Y 31.4%8 of 10 weeks ahead 70% evidence |
| Exact sum: 7.8 + 7.1 + 3.6 + 11.2 = 29.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 54Quick Heal Technologies LtdQUICKHEAL | 18.9/100Adverse evidence69% evidence | ASLEEP | 6.2/35 Revenue -6.6% · PAT -80% · OPM change -22.1 pp 71% evidence | 1.8/25 ROCE -4.7% · OPM -39% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 0.9/20 RS sector -35.1% · RS bench -33% · 1Y -45.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 6.2 + 1.8 + 10 + 0.9 = 18.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 55Covance Softsol Ltd544361 | 67.0/100Thin evidence · provisional49% evidence | 25.8/35 Revenue 43.5% · PAT 100% · OPM change 19.7 pp 62% evidence | 17.8/25 ROCE 31.4% · OPM 23.1% 76% evidence | 11.2/20 P/E 12.9× · PEG — 15% evidence | 12.2/20 RS sector — · RS bench 48.4% · 1Y — 25% evidence | |
| Exact sum: 25.8 + 17.8 + 11.2 + 12.2 = 67 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 56Exato Technologies Ltd544626 | 58.1/100Thin evidence · provisional38% evidence | 21.0/35 Revenue — · PAT — · OPM change 3.4 pp 45% evidence | 17.6/25 ROCE 26.8% · OPM 18% 76% evidence | 9.5/20 P/E 32.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y — 0% evidence | |
| Exact sum: 21 + 17.6 + 9.5 + 10 = 58.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 57Meta Infotech LtdMETA | 54.5/100Thin evidence · provisional21% evidence | 17.0/35 Revenue — · PAT — · OPM change -2 pp 10% evidence | 16.4/25 ROCE 51.1% · OPM 8% 57% evidence | 11.1/20 P/E 13× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y -42.1%0 of 12 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 17 + 16.4 + 11.1 + 10 = 54.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 58Kody Technolab LtdKODYTECH | 52.7/100Thin evidence · provisional48% evidence | TURNING | 15.2/35 Revenue — · PAT — · OPM change -5 pp 19% evidence | 13.1/25 ROCE 16.8% · OPM 29% 95% evidence | 8.7/20 P/E 119× · PEG — 15% evidence | 15.7/20 RS sector 10.3% · RS bench 56.2% · 1Y 79.3%7 of 10 weeks ahead 70% evidence |
| Exact sum: 15.2 + 13.1 + 8.7 + 15.7 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 59Unified Data- Tech Solutions LtdUNIFIED | 52.6/100Thin evidence · provisional22% evidence | 15.8/35 Revenue — · PAT — · OPM change -8 pp 15% evidence | 16.9/25 ROCE 47.9% · OPM 13% 57% evidence | 9.9/20 P/E 23.2× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y 14.8%0 of 12 weeks ahead to 2026-03-08 0% evidence | |
| Exact sum: 15.8 + 16.9 + 9.9 + 10 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 60Trident Techlabs LtdTECHLABS | 46.1/100Thin evidence · provisional40% evidence | 16.0/35 Revenue — · PAT — · OPM change -2 pp 15% evidence | 16.1/25 ROCE 26.7% · OPM 27% 71% evidence | 10.8/20 P/E 14.9× · PEG — 15% evidence | 3.2/20 RS sector -50.3% · RS bench -56.5% · 1Y -60%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 16 + 16.1 + 10.8 + 3.2 = 46.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 61ERP Soft Systems Ltd530909 | 44.4/100Thin evidence · provisional41% evidence | 19.9/35 Revenue 19.1% · PAT 100% · OPM change -1.1 pp 53% evidence | 8.0/25 ROCE 1.6% · OPM 1.7% 57% evidence | 8.9/20 P/E 74.9× · PEG — 15% evidence | 7.6/20 RS sector — · RS bench -47.6% · 1Y -55%0 of 12 weeks ahead to 2026-03-29 25% evidence | |
| Exact sum: 19.9 + 8 + 8.9 + 7.6 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 62Veefin Solutions LtdVEEFIN | 43.3/100Thin evidence · provisional33% evidence | 17.0/35 Revenue — · PAT — · OPM change -12.4 pp 5% evidence | 10.4/25 ROCE 6.8% · OPM 20% 57% evidence | 9.3/20 P/E 40.5× · PEG — 15% evidence | 6.6/20 RS sector -7.2% · RS bench -18.7% · 1Y -24.3%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 17 + 10.4 + 9.3 + 6.6 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 63IDream Film Infrastructure Company Ltd504375 | 38.4/100Thin evidence · provisional35% evidence | TURNING | 12.8/35 Revenue — · PAT 0% · OPM change — 33% evidence | 3.1/25 ROCE -9.2% · OPM -25.8% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 132.9% · 1Y —5 of 5 weeks ahead 25% evidence |
| Exact sum: 12.8 + 3.1 + 10 + 12.5 = 38.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 64Orient Technologies LtdORIENTTECH | 33.4/100Thin evidence · provisional48% evidence | ASLEEP | 15.2/35 Revenue — · PAT — · OPM change -0.5 pp 19% evidence | 2.5/25 ROCE 8.4% · OPM 6.7% 95% evidence | 9.0/20 P/E 47.2× · PEG — 15% evidence | 6.7/20 RS sector -7.1% · RS bench -17.7% · 1Y -7.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 15.2 + 2.5 + 9 + 6.7 = 33.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is RNIT AI Solutions Ltd's share price today?
RNIT AI Solutions Ltd trades at ₹56.5. The company is valued at ₹646 Cr. The stock sits at 48% of its 52-week range of ₹42–₹73, +5.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 37 weeks in. — as of 14 August 2026.
What were RNIT AI Solutions Ltd's latest quarterly results?
RNIT AI Solutions Ltd reported revenue of ₹7.8 Cr and net profit of ₹1.3 Cr for the Jun 26 quarter. Revenue rose 25.6% and profit rose 54.9% year on year. Earnings per share were ₹0.15. The operating margin was 35.3%, 0.6 pp lower than a year earlier. — as of 14 August 2026.
What is RNIT AI Solutions Ltd's revenue?
RNIT AI Solutions Ltd reported revenue of ₹7.8 Cr in the Jun 26 quarter, +25.6% year on year. For the full FY26 fiscal year, revenue was ₹52.0 Cr (+62.5%). Over the last 16 years revenue compounded at 22.6% a year. — as of 14 August 2026.
What is RNIT AI Solutions Ltd's profit?
RNIT AI Solutions Ltd earned ₹1.3 Cr of net profit in the Jun 26 quarter, +54.9% year on year — the 5th straight quarter of growth. Full-year FY26 profit was ₹12.0 Cr. The operating margin ran 35.3% in the latest quarter. — as of 14 August 2026.
What is RNIT AI Solutions Ltd's market cap?
RNIT AI Solutions Ltd's market capitalisation is ₹646 Cr at a share price of ₹56.5. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is RNIT AI Solutions Ltd's P/E ratio?
RNIT AI Solutions Ltd trades at a P/E of 51.8×, at the 96th percentile of its own 1-year range, against a long-run median of 42.9×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does RNIT AI Solutions Ltd pay a dividend?
No — RNIT AI Solutions Ltd has recorded a dividend payout of 0% of profit in each of its last 13 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 14 August 2026.
Is RNIT AI Solutions Ltd overvalued?
On its own history, RNIT AI Solutions Ltd looks expensive: its P/E of 51.8× sits at the 96th percentile of its 1-year range (long-run median 42.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 14 August 2026.
Is RNIT AI Solutions Ltd growing?
Yes — RNIT AI Solutions Ltd is growing: latest-quarter revenue +25.6% year on year, profit +54.9%, and the margin −0.6 pp at 35.3%. The 16-year compound rates are 22.6% (revenue) and 16.8% (profit). The earnings engine currently reads: improving — as of 14 August 2026.
How is RNIT AI Solutions Ltd performing?
RNIT AI Solutions Ltd is in a confirmed uptrend, 37 weeks in. Its latest quarter's revenue rose 25.6% and profit rose 54.9% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 9 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
Is RNIT AI Solutions Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 37 of stage 2), trading +5.6% versus its 200-day average and at 48% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is RNIT AI Solutions Ltd beating the market?
Not lately — on a trailing-13-week view RNIT AI Solutions Ltd is currently behind the NIFTY 500 (9 weeks and counting; last ahead the week of 2026-06-10), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 8 months the stock moved +8% against the NIFTY 500's −3% — ahead of the index over the full window. — as of 14 August 2026.
Will RNIT AI Solutions Ltd's share price go up?
This page publishes no price forecast for RNIT AI Solutions Ltd. What it measures instead: the share price is ₹56.5, the price is in a confirmed uptrend 37 weeks in. Its P/E of 51.8× sits at the 96th percentile of its own 1-year range. — as of 14 August 2026.
Who owns RNIT AI Solutions Ltd?
Promoters hold 63.2% of RNIT AI Solutions Ltd, foreign institutions 0.0%, domestic institutions 1.7% and the public 35.0% (latest quarter). The biggest move on the register over the last two years: Promoters added 11.0 points over 8 quarters. — as of 14 August 2026.
Does RNIT AI Solutions Ltd have too much debt?
No — RNIT AI Solutions Ltd's debt-to-equity is 0.13, and operating profit covers the interest bill 21×. FY26 borrowings were ₹18.0 Cr against equity of ₹139 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is RNIT AI Solutions Ltd's capex?
RNIT AI Solutions Ltd spent ₹80.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹19.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is RNIT AI Solutions Ltd's cash flow?
RNIT AI Solutions Ltd generated ₹11.0 Cr of operating cash flow in FY26 and ₹−8.0 Cr of free cash flow after ₹19.0 Cr of capital spending. Reported profit that year was ₹12.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is RNIT AI Solutions Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 15% of RNIT AI Solutions Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹11.0 Cr against reported profit of ₹12.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 14 August 2026.
Where is RNIT AI Solutions Ltd in its business cycle?
RNIT AI Solutions Ltd's FY26 operating margin was 40.0%, against a 12-year band of −555.0%–40.0%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 35.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the RNIT AI Solutions Ltd story?
The sharpest disagreement: profits are rising, but only 15% of the last 3 years' profit arrived as operating cash — the gap between the P&L and the bank account is the thing to watch. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is RNIT AI Solutions Ltd a stock worth studying right now?
This is not investment advice. The machine read: RNIT AI Solutions Ltd is strength at full price. The numbers are improving — and a P/E at the 96th percentile of its own range says the market knows. The sharpest open question: whether the cash starts following the profit. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.